VC  Affinity Capital Management

     Office Locations:

901 Marquette Avenue, Suite 2820
Minneapolis, MN 55402
Phone: 612-252-9900
Fax: 612-252-9911



  • Early
  • Expansion
  • Growth
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Based in Minneapolis, Affinity has managed over $165 million since its inception in 1993. Affinity is currently investing its fifth fund, Affinity Capital V. The firm invests in health care companies, from new devices and treatments to improved cost effective care and more efficient and affordable technology systems. Historically, Affinity has invested in companies in all phases of development - from start-ups seeking seed capital to growing companies looking to expand their market opportunity. While Affinity will retain this broad interest, the fifth fund will focus on investment opportunities that possess reasonable expectations of success within a three to five year timeframe.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    B. Kristine Johnson President
    Edson W. Spencer Jr. Founder and Chairman
    Gregory T. Glarner Venture Partner
    Robin M. Dowdle CFO
    Serafin Y. Samson Venture Partner


    Portfolio companies include:

      Anulex Technologies
        web link

        web link

        web link

      Botanical Laboratories
        web link

      Cardiac Concepts
        web link

        web link

        web link

      Data Sciences International
        web link

        web link


      iScience Interventional
        web link

      Isis Parenting
        web link

        web link

      National Dentex
        web link

      Novasys Medical
        web link

        web link

      Proteus Digital Health
        web link

        web link

      Sonitus Medical
        web link

        web link

      Uptake Medical
        web link


    Recent News: